Supplier
Wellstreet Urgent Care of Michigan
Wellstreet Urgent Care of Michigan was paid $37.45M by Medicaid between Feb 2019 and Dec 2024, across 83 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 23% of everything it billed.
33Billing provider infoWELLSTREET URGENT CARE OF MICHIGAN
WEST BLOOMFIELD, MI 48322
WEST BLOOMFIELD, MI 48322
33aNPI1578048096assigned 10/01/2018
33bProvider typeNon-Pharmacy Dispensing Site
28Total paid$37.45M
24GClaims690,502
24DCodes billed83
24AFirst – last monthFeb 2019 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 25,514 | $1.01M | |
| 2020 | 76,359 | $2.97M | |
| 2021 | 148,015 | $7.61M | |
| 2022 | 162,352 | $9.90M | |
| 2023 | 152,413 | $8.98M | |
| 2024incomplete | 125,849 | $6.98M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 110,972 | 104,419 | $8.72M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22% | 83,227 | 80,076 | $8.37M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 19% | 89,975 | 89,464 | $7.15M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 14% | 44,018 | 43,799 | $5.22M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6.1% | 54,294 | 51,250 | $2.30M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.2% | 43,806 | 41,949 | $1.19M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.7% | 4,774 | 4,727 | $627K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.4% | 31,557 | 24,267 | $512K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.3% | 9,645 | 9,596 | $469K |
| 99205 | Prolong outpt/office vis | 1.2% | 3,012 | 3,001 | $457K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 31,976 | 31,501 | $371K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 4,569 | 4,411 | $249K |
71 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 21,660 | $181K |
| 81025 | <1% | 27,121 | $168K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 4,923 | $144K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 3,238 | $132K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 7,136 | $117K |
| 93000 | <1% | 7,787 | $101K | |
| 73130 | <1% | 4,609 | $91K | |
| 81003 | <1% | 38,892 | $88K | |
| 73630 | <1% | 4,655 | $83K | |
| 73610 | <1% | 3,768 | $74K | |
| 73564 | <1% | 2,481 | $58K | |
| 12001 | <1% | 967 | $58K | |
| 73110 | <1% | 2,136 | $46K | |
| 90715 | <1% | 1,481 | $43K | |
| S9083 | Global fee urgent care centers | <1% | 4,179 | $41K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 8,521 | $40K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,225 | $35K |
| 69210 | <1% | 908 | $33K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 3,811 | $32K |
| 10060 | <1% | 301 | $23K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,968 | $22K |
| 73030 | <1% | 1,215 | $21K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,641 | $21K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,388 | $19K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,794 | $18K |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 1,651 | $14K |
| 71101 | <1% | 625 | $13K | |
| 73080 | <1% | 521 | $9K | |
| 87807 | <1% | 640 | $7K | |
| 72100 | <1% | 351 | $7K | |
| 87631 | <1% | 70 | $7K | |
| E0114 | Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips | <1% | 254 | $6K |
| 82962 | <1% | 2,001 | $5K | |
| 86308 | <1% | 1,355 | $5K | |
| 73590 | <1% | 274 | $4K | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 115 | $4K |
| 74019 | <1% | 167 | $3K | |
| L1902 | Ankle orthosis, ankle gauntlet or similar, with or without joints, prefabricated, off-the-shelf | <1% | 84 | $3K |
| L3809 | Wrist hand finger orthosis, without joint(s), prefabricated, off-the-shelf, any type | <1% | 29 | $3K |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 486 | $3K |
| 73090 | <1% | 191 | $3K | |
| 73502 | <1% | 106 | $3K | |
| 69209 | <1% | 180 | $3K | |
| 26010 | <1% | 12 | $2K | |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | <1% | 1,390 | $2K |
| 29125 | <1% | 54 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 91 | $2K |
| L4361 | Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf | <1% | 12 | $2K |
| 29130 | <1% | 82 | $2K | |
| 12002 | <1% | 25 | $2K | |
| 90714 | <1% | 67 | $2K | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 1,146 | $1K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 271 | $1K |
| L3260 | Surgical boot/shoe, each | <1% | 99 | $1K |
| 87905 | <1% | 98 | $725.64 | |
| 84703 | <1% | 94 | $645.73 | |
| Q4049 | Finger splint, static | <1% | 300 | $554.54 |
| 29515 | <1% | 12 | $471.12 | |
| 99201 | <1% | 17 | $458.25 | |
| A4565 | Slings | <1% | 132 | $409.26 |
| 90674 | <1% | 17 | $350.76 | |
| 90688 | <1% | 16 | $299.68 | |
| 74018 | <1% | 12 | $259.63 | |
| Q4022 | Cast supplies, short arm splint, adult (11 years +), fiberglass | <1% | 12 | $108.27 |
| 99421 | <1% | 27 | $75.00 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 26 | $70.20 |
| 82948 | <1% | 13 | $41.80 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 26 | $41.36 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 293 | $35.17 |
| 81002 | <1% | 14 | $25.92 | |
| 99051 | 0% | 414 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRESNICK, LEE (CHIEF MEDICAL OFFICER)